Tivity Health - TVTY Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Tivity Health in the last year. There are currently 4 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" TVTY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TVTY, but not buy additional shares or sell existing shares.
View TVTY analyst ratings or view top-rated stocks.

4 equities research analysts have issued 12-month price targets for Tivity Health's stock. Their TVTY share price forecasts range from $30.00 to $35.00. On average, they anticipate the company's share price to reach $32.00 in the next year. This suggests that the stock has a possible downside of 1.5%.
View analysts price targets for TVTY or view top-rated stocks among Wall Street analysts.

Tivity Health's stock was trading at $26.44 at the start of the year. Since then, TVTY stock has increased by 22.9% and is now trading at $32.50.
View the best growth stocks for 2022 here.

Tivity Health, Inc. (NASDAQ:TVTY) posted its earnings results on Tuesday, November, 2nd. The company reported $0.42 EPS for the quarter, topping the consensus estimate of $0.36 by $0.06. The business had revenue of $126.29 million for the quarter, compared to analysts' expectations of $122.39 million. Tivity Health had a trailing twelve-month return on equity of 75.94% and a net margin of 17.25%. During the same quarter last year, the business earned $0.72 earnings per share.

8 employees have rated Tivity Health Chief Executive Officer Richard Ashworth on Glassdoor.com. Richard Ashworth has an approval rating of 36% among the company's employees. This puts Richard Ashworth in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Tivity Health investors own include NVIDIA (NVDA), Energy Transfer (ET), Pfizer (PFE), Advanced Micro Devices (AMD), AT&T (T), Sorrento Therapeutics (SRNE), Applied Materials (AMAT), Inovio Pharmaceuticals (INO) and Novavax (NVAX).

Tivity Health trades on the NASDAQ under the ticker symbol "TVTY."

Shares of TVTY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TVTY stock can currently be purchased for approximately $32.50.

Tivity Health (NASDAQ:TVTY) has a market capitalization of $1.62 billion and generates $481.25 million in revenue each year. The company earns $104.91 million in net income (profit) each year or $1.71 on an earnings per share basis.

The company employs 380 workers across the globe.

Tivity Health was founded in 2017.

Tivity Health's mailing address is 701 Cool Springs Boulevard, Franklin TN, 37067. The official website for the company is www.tivityhealth.com. The company can be reached via phone at (800) 869-5311, via email at investor.relations@tivityhealth.com, or via fax at 302-674-5266.